Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy-Reference-Cited by-同舟云学术

Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy

Published:2016-07-11 Issue:1 Volume:89 Page:85-90
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Kim Mi Na¹,Park Jun Yong²³⁴,Ahn Sang Hoon²³⁴,Kim Beom Kyung²³⁴,Kim Seung Up²³⁴,Kim Do Young²³⁴,Han Kwang-Hyub²³⁴

Affiliation:

1. Department of Internal Medicine, CHA Bundang Medical Center; CHA University; Seongnam Korea

2. Department of Internal Medicine; Yonsei University College of Medicine; Seoul Korea

3. Institute of Gastroenterology; Yonsei University College of Medicine; Seoul Korea

4. Yonsei Liver Center; Yonsei University Health System; Seoul Korea

Funder

Centers for Disease Control and Prevention

Ministry of Education

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference37 articles.

1. Management of hepatitis B in developing countries;Abbas;World J Hepatol,2011

2. Overlap/switch to adefovir monotherapy for lamivudine-resistant patients who responded to combination therapy: A pilot controlled study;Aizawa;Intern Med,2010

3. High rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with lamivudine: Results of an open labeled trial;Alexander;BMC Gastroenterol,2005

4. On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients;Cai;J Clin Virol,2010

5. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B;Chang;N Engl J Med,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination Therapy;Hepatitis B Virus and Liver Disease;2021

2. An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate;Journal of Viral Hepatitis;2020-01

3. Step-down strategy in antiviral resistant chronic hepatitis B patients who achieved viral suppression with rescue combination therapy;Future Virology;2018-10-01

4. Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance;J MED VIROL;2018

5. Combination Therapy;Hepatitis B Virus and Liver Disease;2017-09-07